Sheppard et al., 1994 - Google Patents
Expression of cystic fibrosis transmembrane conductance regulator in a model epitheliumSheppard et al., 1994
- Document ID
- 9264913261544401655
- Author
- Sheppard D
- Carson M
- Ostedgaard L
- Denning G
- Welsh M
- Publication year
- Publication venue
- American Journal of Physiology-Lung Cellular and Molecular Physiology
External Links
Snippet
Cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl-channel regulated by adenosine 3', 5'-cyclic monophosphate (cAMP)-dependent phosphorylation and by intracellular nucleotides. The function of CFTR, like other recombinant ion channels, has …
- 102000012605 Cystic Fibrosis Transmembrane Conductance Regulator 0 title abstract description 134
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4712—Cystic fibrosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sheppard et al. | Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium | |
| Bear et al. | Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR) | |
| Kullak‐Ublick et al. | Functional characterization of the basolateral rat liver organic anion transporting polypeptide | |
| Taglialatela et al. | C‐terminus determinants for Mg2+ and polyamine block of the inward rectifier K+ channel IRK1. | |
| Eghbali et al. | Expression of gap junction channels in communication-incompetent cells after stable transfection with cDNA encoding connexin 32. | |
| Ismailov et al. | Role of actin in regulation of epithelial sodium channels by CFTR | |
| Schwiebert et al. | Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents | |
| Cheng et al. | Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression | |
| Cozens et al. | Characterization of immortal cystic fibrosis tracheobronchial gland epithelial cells. | |
| Kunzelmann et al. | Na+ and Cl− conductances in airway epithelial cells: increased Na+ conductance in cystic fibrosis | |
| Travis et al. | Interaction of nucleotides with membrane-associated cystic fibrosis transmembrane conductance regulator | |
| Mangoo-Karim et al. | Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells | |
| Marsh et al. | Interactions of Semliki Forest virus spike glycoprotein rosettes and vesicles with cultured cells. | |
| Egan et al. | Differential expression of ORCC and CFTR induced by low temperature in CF airway epithelial cells | |
| Konstas et al. | cAMP-dependent activation of CFTR inhibits the epithelial sodium channel (ENaC) without affecting its surface expression | |
| US5543399A (en) | Cystic fibrosis transmembrane conductance regulator (CFTR) protein | |
| Lavelle et al. | Low permeabilities of MDCK cell monolayers: a model barrier epithelium | |
| McCray Jr et al. | Expression of CFTR and a cAMP-stimulated chloride secretory current in cultured human fetal alveolar epithelial cells | |
| Mitchell et al. | A synthetic peptide based on a glycine-gated chloride channel induces a novel chloride conductance in isolated epithelial cells | |
| Faller et al. | Evidence for location of the CFTR in human placental apical membrane vesicles | |
| Pitkanen et al. | Fetal lung cell-derived matrix alters distal lung epithelial ion transport | |
| Schillers | Imaging CFTR in its native environment | |
| CA2061579C (en) | Cystic fibrosis transmembrane conductance regulator (cftr) protein | |
| Liedtke | Electrolyte transport in the epithelium of pulmonary segments of normal and cystic fibrosis lung 1 | |
| US5985824A (en) | Methods and compositions for treating cystic fibrosis |